The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design

Abstract Background Neurological disability progression occurs across the spectrum of people living with multiple sclerosis (MS). Although there are a handful of disease-modifying treatments approved for use in progressive phenotypes of MS, there are no treatments that substantially modify the cours...

Full description

Bibliographic Details
Main Authors: Jiwon Oh, Nathalie Arbour, Fabrizio Giuliani, Melanie Guenette, Shannon Kolind, Larry Lynd, Ruth Ann Marrie, Luanne M. Metz, Scott B. Patten, Alexandre Prat, Alice Schabas, Penelope Smyth, Roger Tam, Anthony Traboulsee, V. Wee Yong
Format: Article
Language:English
Published: BMC 2021-10-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Cohort
Prospective
Progression
Progressive MS
Epidemiology
Online Access:https://doi.org/10.1186/s12883-021-02447-7

Internet

https://doi.org/10.1186/s12883-021-02447-7

Similar Items